Characterization of TPO Receptor Agonists for the Management of Thrombocytopenia after CAR T-cell Therapy

Key Points

• Thrombocytopenia management relies on targeted tpo receptor agonists, leading to improved outcomes.
• In the analysis, response rates reached up to 70% among patients treated with these agonists.
• Assessment included various tpo receptor agonists and their effects on platelet production post-therapy.
• Findings highlight the need for long-term studies and broader validation in diverse populations.